mednous.com Report : Visit Site

Technical data of the mednous.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host mednous.com. Currently, hosted in Singapore and its service provider is CloudFlare Inc. .

the related websites

medherant.co.uk txcell.com epvantage.com kymab.com kilburnstrode.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called cloudflare containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to main content 7 june 2018 last updated: thursday 7 june 2018 user account menu log in register & subscribe search this site: search primary links home news about mednous research directory contact us evernow publishing ltd privacy policy. read more . subscribe to mednous and get ahead in the business of medical innovation. subscribe now . the latest mednous journal. subscribe to download . free featured article microbiotica to collaborate with genentech thursday 7 june 2018 country united kingdom a short 18 months after its launch as a new company, microbiotica ltd has entered into a multi-year collaboration with genentech, a member of the roche group, to discover, develop and commercialise biomarkers, targets and medicines for inflammatory bowel disease (ibd). microbiotica was spun out of the wellcome trust sanger institute in 2016 to research the human microbiome, a term used to describe the genomes of microorganisms in the gut, including at least 1,000 species of bacteria. read more hookipa secures licencing deal with gilead tuesday 5 june 2018 country austria hookipa biotech ag has signed a licencing deal with gilead sciences inc giving the us company exclusive rights to its technology platform to develop vaccines targeting the hepatitis b and the human immunodeficiency viruses. the agreement brings austria-based read more positive ema opinion for aimovig monday 4 june 2018 country united kingdom the european medicines agency has issued a positive opinion for aimovig (erenumab), an antibody treatment for migraine prevention, only weeks after it was given approval by the us food and drug administration. both agencies highlighted the novelty of the drug read more second phase 3 failure for az’s fasenra monday 4 june 2018 country united kingdom read more fda approves first artificial iris friday 1 june 2018 country united states read more the enforcer of data protection steps into the spotlight wednesday 30 may 2018 country belgium read more astrazeneca divests seroquel tuesday 29 may 2018 country united kingdom read more daratumumab combination studies stopped monday 28 may 2018 country denmark read more medigene raises €32.3 million in private placement monday 28 may 2018 country germany read more european venture to develop pain medication thursday 24 may 2018 country switzerland read more cancer vaccine collaboration tuesday 22 may 2018 country united states read more avacta produces protein therapeutics in mice tuesday 22 may 2018 country united kingdom read more medigene expands tcr alliance tuesday 22 may 2018 country germany read more looking for more? visit our news section for more articles. news our full mednous news archive appointments latest industry appointments events a list of upcoming industry events about mednous mednous is a print publication and a website for everyone involved in medical research in europe. read more free article ownership lessons for european biotechs by john rountree ownershiplessonsforbiotech johnrountree may2018.pdf latest mednous issue highlights mednous may 2018 the may 2018 mednous features: business strategy ownership lessons for european biotechs by john rountree research strategy sourcing antibiotics from the nematode worm interview with nosopharm oncology review beneath the statistics: new modes of action in oncology by bruno pagliara the inventive step using nanotechnology to improve aids medication by peter charlish business strategy european pharma plots new directions for r&d by jean-claude muller commentary patch up the pain: a case study in transdermal drug delivery by vasiliki nikolaou and david haddleton the latest mednous journal. subscribe to download . select a news category clinical research company news finance, grants, deals ipr & legal regenerative medicine regulation & policy research & university news recent appointments gerben moolhuizen appointed ceo of isa pharmaceuticals tuesday may 29 2018 harren jhoti named fellow of the royal society friday may 18 2018 stephen eck appointed cmo at immatics friday may 18 2018 daniel menichella to become ceo of curevac monday may 14 2018 soenke brunswieck joins celonic monday may 14 2018 © 2018 evernow publishing ltd . powered by drupal .

URL analysis for mednous.com

https://www.mednous.com/news/microbiotica-collaborate-genentech
https://www.mednous.com/category/news-topic/clinical-research
https://www.mednous.com/#main-content
https://www.mednous.com/news/avacta-produces-protein-therapeutics-mice
https://www.mednous.com/system/files/2018-05/ownershiplessonsforbiotech%20johnrountree%20may2018.pdf
https://www.mednous.com/category/news-topic/regulation-policy
https://www.mednous.com/news/cancer-vaccine-collaboration
https://www.mednous.com/appointment/soenke-brunswieck-joins-celonic
https://www.mednous.com/contact-us
https://www.mednous.com/category/news-topic/company-news
https://www.mednous.com/news/european-venture-develop-pain-medication
https://www.mednous.com/appointment/harren-jhoti-named-fellow-royal-society
https://www.mednous.com/news/daratumumab-combination-studies-stopped
https://www.mednous.com/appointment/gerben-moolhuizen-appointed-ceo-isa-pharmaceuticals
https://www.mednous.com/category/news-topic/research-university-news

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: MEDNOUS.COM
Registry Domain ID: 988075271_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enom.com
Updated Date: 2017-04-11T17:35:14Z
Creation Date: 2007-05-22T13:09:28Z
Registry Expiry Date: 2021-05-22T13:09:28Z
Registrar: eNom, Inc.
Registrar IANA ID: 48
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: ALINA.NS.CLOUDFLARE.COM
Name Server: PETE.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-20T23:17:58Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR eNom, Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =mednous.com

  PORT 43

  TYPE domain

DOMAIN

  NAME mednous.com

  CHANGED 2017-04-11

  CREATED 2007-05-22

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  ALINA.NS.CLOUDFLARE.COM 173.245.58.61

  PETE.NS.CLOUDFLARE.COM 173.245.59.136

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .